6,000+ Customers. 300+ Integrations. One Voice for the Brand. You are a high-performer. You dont need someone hovering over your shoulder to tell the difference between good copy and copy that converts. You understand SaaS marketing,
What its about Partners Group has been a leading innovator of client solutions for the Private Wealth segment. In this segment Partner Group caters via wholesale/distribution sales channels to private wealth clients. The firm has been
Global Marketing Director, Oncology Location: Zug - Switzerland, GSK HQ - London or Upper Providence - USA GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion
Overview You lead the development and execution of the 5-year PO&T Asset Strategy and an 18-month Tactical Plan, guiding cross-functional teams to optimize asset value. You act as the liaison between PO&T, R&D, and PDC, shaping
Overview In this role you support audits and NAV processes for a diversified portfolio, partnering with external fund administrators, auditors, and internal teams. You will review financial statements and reports, flagting issues and driving timely, high-quality
Overview In this role you partner data science with internal audit to strengthen risk identification through data-driven tests. You will execute audits across diverse areas, turning data into actionable findings with Python, SQL, and AI techniques.
Overview In this role you will lead and support the design, testing, and qualification of distribution packaging and cold chain solutions across global sites. You’ll collaborate with Logistics, Quality, and partners to ensure compliant, efficient temperature-controlled
Overview In this role, you will support the Private Wealth Client Solutions team in acquiring and maintaining clients, evolving open- and closed-ended funds, and producing persuasive marketing materials. You will collaborate with internal stakeholders and progress
Global Marketing Director, Oncology Location: Zug - Switzerland, GSK HQ - London or Upper Providence - USA GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion